What is the recommended antibiotic treatment for an otherwise healthy, non-pregnant woman with acute cystitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotic Treatment for Acute Uncomplicated Cystitis

Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days is the preferred first-line treatment for acute uncomplicated cystitis in otherwise healthy, non-pregnant women. 1

First-Line Treatment Options

Nitrofurantoin monohydrate/macrocrystals is the optimal choice because it demonstrates:

  • Clinical cure rates of 88-93% and bacterial cure rates of 81-92% 1
  • Minimal resistance patterns and limited collateral damage to normal flora 1
  • Efficacy comparable to ciprofloxacin (93% vs 95%) and trimethoprim-sulfamethoxazole (93% vs 95%) 1
  • Dose: 100 mg twice daily for 5 days 2, 1

Trimethoprim-sulfamethoxazole is an acceptable alternative ONLY if:

  • Local resistance rates are confirmed to be <20% 2, 1
  • The patient has not used it for UTI in the previous 3 months 2
  • Dose: 160/800 mg (one double-strength tablet) twice daily for 3 days 2, 1
  • Critical caveat: Efficacy drops dramatically against resistant organisms (41-54% cure rate vs 84-88% for susceptible strains) 1

Fosfomycin trometamol serves as another first-line option when others cannot be used:

  • Single 3-gram dose 2, 1
  • Clinical cure rates approximately 90%, though microbiological cure may be lower (78% vs 86% for nitrofurantoin) 1
  • Should be avoided if early pyelonephritis is suspected 2

Alternative Agents (When First-Line Options Cannot Be Used)

Fluoroquinolones (ciprofloxacin, levofloxacin, ofloxacin, norfloxacin):

  • Highly effective in 3-day regimens 2, 1
  • Should be reserved as alternatives due to their propensity for collateral damage and promotion of resistance 2, 1
  • Use only when first-line agents are contraindicated 2

β-Lactam agents (amoxicillin-clavulanate, cefdinir, cefaclor, cefpodoxime-proxetil):

  • Require 3-7 day regimens 2, 1
  • Generally have inferior efficacy and more adverse effects compared to first-line options 2, 1
  • Use only when recommended agents cannot be used 2
  • Cephalexin is less well-studied but may be appropriate in certain settings 2

Agents to Avoid

Never use amoxicillin or ampicillin empirically due to:

  • Poor efficacy 2
  • Very high prevalence of antimicrobial resistance worldwide 2, 1

Decision Algorithm

  1. Start with nitrofurantoin 100 mg twice daily for 5 days unless contraindicated 1

  2. If nitrofurantoin cannot be used, consider:

    • Trimethoprim-sulfamethoxazole IF local resistance <20% AND no recent use 2, 1
    • Fosfomycin 3 g single dose (accept slightly lower efficacy) 2, 1
  3. If all first-line options are contraindicated, use fluoroquinolones for 3 days 2, 1

  4. Reserve β-lactams as last resort when no other options available 2

Common Pitfalls to Avoid

  • Do not use trimethoprim-sulfamethoxazole empirically without knowing local resistance patterns or if the patient used it recently 2, 1
  • Avoid nitrofurantoin and fosfomycin if you suspect early pyelonephritis (fever, flank pain, systemic symptoms) as they have inadequate tissue penetration 2
  • Do not prescribe fluoroquinolones as first-line despite their high efficacy—reserve them for more serious infections 2, 1
  • Never use short-course regimens (3-5 days) in males—this requires 7-14 day treatment with different agents 3

References

Guideline

Cystitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Cystitis in Males

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.